Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials.

D Y C Heng; T K Choueiri; B I Rini; J Lee; T Yuasa; S K Pal; S Srinivas; G A Bjarnason; J J Knox; M Mackenzie; U N Vaishampayan; M H Tan; S Y Rha; F Donskov; N Agarwal; C Kollmannsberger; S North; L A Wood

首页> 外文期刊>Annals of oncology: official journal of the European Society for Medical Oncology >Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials.

【24h】

Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials.

机译：不符合临床试验资格标准的转移性肾细胞癌患者的治疗结果。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The number of patients that are ineligible for clinical trials is substantial and their outcomes are inferior. Specific trials addressing the unmet needs of protocol ineligible patients are warranted.

机译：不符合临床试验条件的患者人数很多，其结果也较差。有必要针对符合方案的患者的未满足需求进行特定试验。

著录项

来源
《Annals of oncology: official journal of the European Society for Medical Oncology》 |2014年第1期|共6页
作者
D Y C Heng; T K Choueiri; B I Rini; J Lee; T Yuasa; S K Pal; S Srinivas; G A Bjarnason; J J Knox; M Mackenzie; U N Vaishampayan; M H Tan; S Y Rha; F Donskov; N Agarwal; C Kollmannsberger; S North; L A Wood;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials. [J] . D Y C Heng, T K Choueiri, B I Rini, Annals of oncology: official journal of the European Society for Medical Oncology . 2014,第1期

机译：不符合临床试验资格标准的转移性肾细胞癌患者的治疗结果。
2. Morphology, Attenuation, Size, and Structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy. [J] . Smith AD, Shah SN, Rini BI, AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences . 2010,第6期

机译：形态，衰减，大小和结构（MASS）标准：在抗血管生成靶向治疗中评估转移性肾细胞癌的反应并预测临床结果。
3. Eligibility Criteria and Endpoints in Metastatic Renal Cell Carcinoma Trials [J] . Wong Sarah E., Quinn David I, Bjarnason Georg A., American Journal of Clinical Oncology: Cancer Clinical Trials . 2020,第8期

机译：转移性肾细胞癌试验中的资格标准和终点
4. When to Treat Metastatic Renal Cell Carcinoma Comorbidities, Systemic Therapy, and Active Surveillance in Metastatic Kidney Cancer [C] . Brian I. Rini Genitourinary Cancers Symposium . 2012

机译：何时治疗转移性肾细胞癌的组合，全身治疗，以及在转移性肾癌中的活跃监测
5. Methodological Approaches for Conducting Claims-Based Studies in Patients Diagnosed with Metastatic Renal Cell Carcinoma [D] . Chun, Danielle S. 2021

机译：用于诊断转移性肾细胞癌的患者的基于权利要求的基于权利要求的方法论方法
6. Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials [O] . D. Y. C. Heng, T. K. Choueiri, B. I. Rini, -1

机译：不符合临床试验资格标准的转移性肾细胞癌患者的治疗结果
7. A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle [O] . A Bashey, S Corringham, J Garrett, 2000

机译：符合单个循环资格标准的转移乳腺癌患者中具有自体干细胞载体的两次高剂量化疗的II期研究

Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials.

摘要

著录项

相似文献

相关主题

期刊订阅